666

ZHEJIANG AUSUN PHARMACEUTICAL

No trades
See on Supercharts
Market capitalization
‪5.92 B‬CNY
‪235.38 M‬CNY
‪761.04 M‬CNY
‪259.94 M‬
Beta (1Y)
1.74

About ZHEJIANG AUSUN PHARMACEUTICAL

CEO
Zhi Guo Zheng
Headquarters
Taizhou
Employees (FY)
‪1.13 K‬
Founded
2010
ISIN
CNE100002XK2
FIGI
BBG00GBHXMB7
Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the manufacture, sale, research and development of pharmaceutical intermediates and raw materials. Its products include prostaglandin, active pharmaceutical ingredient (API), fluorine, and intermediates. The company was founded by Zheng Zhi Guo, Liu Bin and Mou Li Zhi on April 22, 2010 and is headquartered in Taizhou, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 603229 is 10.09 CNY — it has increased by 1.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange ZHEJIANG AUSUN PHARMACEUTICAL stocks are traded under the ticker 603229.
603229 stock is 1.92% volatile and has beta coefficient of 1.74. Check out the list of the most volatile stocks — is ZHEJIANG AUSUN PHARMACEUTICAL there?
Yes, you can track ZHEJIANG AUSUN PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
603229 stock has risen by 4.56% compared to the previous week, the month change is a 7.00% fall, over the last year ZHEJIANG AUSUN PHARMACEUTICAL has showed a 39.11% decrease.
603229 net income for the last quarter is ‪65.14 M‬ CNY, while the quarter before that showed ‪66.52 M‬ CNY of net income which accounts for −2.08% change. Track more ZHEJIANG AUSUN PHARMACEUTICAL financial stats to get the full picture.
Today ZHEJIANG AUSUN PHARMACEUTICAL has the market capitalization of ‪5.92 B‬, it has increased by 3.98% over the last week.
Yes, 603229 dividends are paid annually. The last dividend per share was 0.11 CNY. As of today, Dividend Yield (TTM)% is 0.57%. Tracking ZHEJIANG AUSUN PHARMACEUTICAL dividends might help you take more informed decisions.
ZHEJIANG AUSUN PHARMACEUTICAL dividend yield was 0.34% in 2022, and payout ratio reached 13.66%. The year before the numbers were 0.20% and 14.29% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 603229 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZHEJIANG AUSUN PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
603229 reached its all-time high on May 11, 2022 with the price of 47.90 CNY, and its all-time low was 3.08 CNY and was reached on Oct 19, 2018.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has ‪1.13 K‬ employees. See our rating of the largest employees — is ZHEJIANG AUSUN PHARMACEUTICAL on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZHEJIANG AUSUN PHARMACEUTICAL technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZHEJIANG AUSUN PHARMACEUTICAL stock shows the sell signal. See more of ZHEJIANG AUSUN PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.